TG TherapeuticsvsThermo Fisher Scientific

TGTX and TMO stock compared: price, dividend, valuation and results, from SEC filings.

TGTX

TG Therapeutics, Inc.

$66.12

Value $10.0B

+5.44%
TGTX's page

TMO

Thermo Fisher Scientific Inc

$692.74

Value $257B

+0.87%
TMO's page

TG Therapeutics (TGTX) has a market value of $10.0B and Thermo Fisher Scientific (TMO) $257B. Over the last year, with dividends, TGTX moved +115.4% and TMO +22.6%. The P/E is 94.2 for TGTX and 36.4 for TMO. Dividend yield: TGTX none, TMO 0.27%.

At a glance

The main figures of both. A bar only shows which number is larger, not which is better.

  • Market value

    TGTX$10.0B

    TMO$257B

    TMO is 26 times TGTX

  • Revenue, 12 months

    TGTX$898M

    TMO$47.4B

    TMO is 53 times TGTX

  • Net income, 12 months

    TGTX$106M

    TMO$7.1B

    TMO is 67 times TGTX

  • Operating margin

    TGTX21.5%

    TMO17.9%

    3.6 points apart

  • ROIC

    TGTX11.9%

    TMO8.2%

    3.7 points apart

  • P/E

    TGTX94.2

    TMO36.4

    TGTX is 2.6 times TMO

  • Dividend yield

    TGTX0.0%

    TMO0.3%

    0.3 points apart

  • 5-year return

    TGTX+143.3%

    TMO+10.3%

    133.0 points apart

A fainter bar means a negative number. The 5-year return includes dividends.

The price over time

Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.

TGTX+143.3%

TMO+10.3%

10020020222023202420252026
Returns by period
PeriodTGTXWith dividendsTMOWith dividends
1 year since November 17, 2025+115.4%Price +115.4%+22.6%Price +22.1%
3 years since November 17, 2023+447.8%+76.3% a yearPrice +447.8%+50.0%+14.5% a yearPrice +48.5%
5 years since November 17, 2021+143.3%+19.5% a yearPrice +143.3%+10.3%+2.0% a yearPrice +8.7%
10 years since November 18, 2016+1,020.7%+27.3% a yearPrice +1,020.7%+388.7%+17.2% a yearPrice +375.1%

Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.

Every figure

As on each company's page. A description, not a recommendation: no one figure says which is better.

TGTXTG TherapeuticsTMOThermo Fisher Scientific

Valuation

TGTXTMO
Valuation
Price$66.12$692.74
Market value$10.0B$257B
Enterprise value (EV)$10.2B$293B
P/E94.236.4
P/E, 5-year median–32.7
P/B17.54.7
EV/EBIT52.834.6
Free cash flow yield0.9%2.9%

Results and growth

TGTXTMO
Results and growth
Revenue, 12 months$898M$47.4B
Net income, 12 months$106M$7.1B
Free cash flow, 12 months$86M$7.6B
Earnings per share, 12 months$0.67$18.96
Revenue growth, year on year87.3%3.9%
Revenue growth a year, past+426.7%over 5 years+6.7%over 5 years
EPS growth a year, past–+2.1%over 5 years

Margins and returns on capital

TGTXTMO
Margins and returns on capital
Gross margin82.7%–
Operating margin21.5%17.9%
Net margin11.8%14.9%
ROIC11.9%8.2%
ROE17.6%13.4%

Balance sheet

TGTXTMO
Balance sheet
Cash$557M$6.1B
Total debt$754M$41.4B
Net debt / EBITDA1.03.7
Interest cover4.1×5.5×

Dividends and buybacks

TGTXTMO
Dividends and buybacks
Dividend yield–0.3%
Dividend per share, 12 months–$1.84
Dividend growth a year, past–+14.3%over 5 years
Buyback yield0.9%1.2%
Shareholder yield0.9%1.4%

Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.

Questions: TGTX or TMO

Didn't find what you were looking for?

Ask us
Which is bigger, TG Therapeutics or Thermo Fisher Scientific?

By market value, Thermo Fisher Scientific ($257B) is about 25.7 times TG Therapeutics ($10.0B), at today's prices.

How did TGTX and TMO stock do over the last 10 years?

Since November 18, 2016, TGTX's price moved +1,020.7% and TMO's +375.1%. With dividends: TGTX +1,020.7% (+27.3% a year), TMO +388.7% (+17.2% a year). Past returns do not predict future ones.

Which pays the higher dividend, TGTX or TMO?

The dividend yield at today's price is none for TG Therapeutics and 0.27% for Thermo Fisher Scientific. Over the last twelve months they paid – and $1.84 per share.

What is the P/E of TGTX and TMO?

At today's price, the P/E is 94.2 for TGTX and 36.4 for TMO. It is the share price over the last twelve months' earnings per share.

Which has the higher profit margins, TG Therapeutics or Thermo Fisher Scientific?

Over the last twelve months, the net margin was 11.8% for TG Therapeutics and 14.9% for Thermo Fisher Scientific, and the operating margin 21.5% and 17.9%. Revenue was $898M and $47.4B.

Which is the better investment, TG Therapeutics or Thermo Fisher Scientific?

The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.

Other comparisons

With each of the two, and with the largest in its sector.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

Descriptive data from SEC filings and market prices.